https://scholars.lib.ntu.edu.tw/handle/123456789/582219
標題: | Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity | 作者: | Hsieh T.-H. JIA-HORNG KAO Lai M.-Y. PEI-JER CHEN DING-SHINN CHEN |
公開日期: | 2005 | 出版社: | Scientific Communications International Ltd | 卷: | 104 | 期: | 5 | 起(迄)頁: | 354-358 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Acute hepatitis C has a high frequency of chronic evolution, which may progress to cirrhosis and hepatocellular carcinoma. However, only a small proportion of acute hepatitis C patients are incidentally identified and then treated. Controversial issues regarding treatment of acute hepatitis C include optimal time of treatment initiation, best treatment regimen and appropriate duration of treatment. We report a symptomatic acute hepatitis C patient in the late acute phase evolving into chronicity successfully treated by peginterferon and ribavirin combination therapy for 6 months at late acute phase, with sustained virologic response for up to 18 months. Our findings indicate that combination peginterferon and ribavirin therapy may be as effective in treating acute hepatitis C as it is in chronic hepatitis C. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-24944547565&partnerID=40&md5=ae6d831295a9646d44c20ffb96fd5c62 https://scholars.lib.ntu.edu.tw/handle/123456789/582219 |
ISSN: | 0929-6646 | SDG/關鍵字: | peginterferon alpha2b; ribavirin; alpha2b interferon; antivirus agent; peginterferon alfa-2b; peginterferon alpha2b; ribavirin; adult; alopecia; anamnesis; article; case report; chronic hepatitis; chronicity; clinical feature; dose response; female; fever; hepatitis C; hospital admission; human; insomnia; laboratory test; neurosis; physical examination; side effect; treatment duration; weight reduction; acute disease; drug combination; hepatitis C; Acute Disease; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon Alfa-2b; Ribavirin |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。